BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Therapeutics GmbH 2016 Hamburg, Germany Evotec AG (Xetra:EVT) €14M ($15.8M) Nanoparticle therapeutics Autoimmune; Inflammation Preclinical Mironid Ltd....
BioCentury | Dec 16, 2016
Company News

Mironid, University of Sheffield deal

...Mironid and the university partnered to develop Mironid’s LoAc molecules to treat autosomal dominant polycystic kidney...
...The selective activators of phosphodiesterase-4 (PDE-4) decrease disease-elevated cyclic AMP levels that drive cyst formation. Mironid...
...in time for publication. Mironid Ltd. , Newhouse, U.K. University of Sheffield, Sheffield, U.K. Business: Renal Alicia Parker Mironid Ltd. The...
BioCentury | Jun 27, 2016
Financial News

Mironid completes venture financing

Mironid Ltd. , Newhouse, U.K. Business: Renal, Inflammation, Cancer Date completed: 2016-06-20 Type: Venture financing Raised: L4.3 million ($6.3 million) Investors: Epidarex Capital; Scottish Enterprise; University of Strathclyde WIR Staff cancer Inflammation Renal...
Items per page:
1 - 3 of 3
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Therapeutics GmbH 2016 Hamburg, Germany Evotec AG (Xetra:EVT) €14M ($15.8M) Nanoparticle therapeutics Autoimmune; Inflammation Preclinical Mironid Ltd....
BioCentury | Dec 16, 2016
Company News

Mironid, University of Sheffield deal

...Mironid and the university partnered to develop Mironid’s LoAc molecules to treat autosomal dominant polycystic kidney...
...The selective activators of phosphodiesterase-4 (PDE-4) decrease disease-elevated cyclic AMP levels that drive cyst formation. Mironid...
...in time for publication. Mironid Ltd. , Newhouse, U.K. University of Sheffield, Sheffield, U.K. Business: Renal Alicia Parker Mironid Ltd. The...
BioCentury | Jun 27, 2016
Financial News

Mironid completes venture financing

Mironid Ltd. , Newhouse, U.K. Business: Renal, Inflammation, Cancer Date completed: 2016-06-20 Type: Venture financing Raised: L4.3 million ($6.3 million) Investors: Epidarex Capital; Scottish Enterprise; University of Strathclyde WIR Staff cancer Inflammation Renal...
Items per page:
1 - 3 of 3